[1]
Blauvelt, A., Alonso-Llamazares, J., Bhatia, N., Draelos, Z., DuBois, J., Forman, S., Gooderham, M., Guenthner, S., Hebert, A., Lain, E., Moore, A., Papp, K., Stein Gold, L., Zirwas, M., Kato, S., Snyder, S., Krupa, D., Burnett, P., Berk, D. and Chu, D. 2023. Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s196. DOI:https://doi.org/10.25251/skin.7.supp.196.